BIBLIOGRAPHY
Boekholdt, S. M., Kuivenhoven, J. A., Wareham, N. J. et al. The prospective EPIC (European Prospective Investigation into Cancer and nutrition)–Norfolk population study: Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women. Circulation, 110:1418–1423, 2004.
CARE: The Cholesterol and Recurrent Events Trial Investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med., 335:1001–9, 1996.
Davidson, M. H., McGarry, T., Bettis, R. et al. Ezetimibe coadminis-tered with simvastatin in patients with primary hypercholesterolemia. J. Am. Coll. Cardiol., 40:2125–34, 2002.
Durrington, P. Dyslipidemia. Lancet, 362:717–31, 2003.
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 85:2486–96, 2001.
Gotto, A. M., and Brinton, E. A. Assessing the lower levels of high-density lipoprotein cholesterol as the risk factor in coronary heart disease. In a working group report and update. J. Am. Coll. Cardiol., 43:717–724, 2004.